Effects of GLP-1 agonists and SGLT2 inhibitors during pregnancy and lactation on offspring outcomes: a systematic review of the evidence

AIMS/HYPOTHESIS: Glucagon-like peptide 1 (GLP-1) agonists and sodium-glucose co-transporter-2 (SGLT2) inhibitors are novel drugs which have recently seen rapid uptake in the treatment of type 2 diabetes and obesity. The paucity of data regarding their safety during pregnancy and lactation causes a d...

Descripción completa

Detalles Bibliográficos
Autores principales: Muller, Dion R. P., Stenvers, Dirk J., Malekzadeh, Arjan, Holleman, Frederik, Painter, Rebecca C., Siegelaar, Sarah E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597691/
https://www.ncbi.nlm.nih.gov/pubmed/37881498
http://dx.doi.org/10.3389/fendo.2023.1215356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10597691/
https://www.ncbi.nlm.nih.gov/pubmed/37881498
http://dx.doi.org/10.3389/fendo.2023.1215356

Ejemplares similares